Sumitovant Biopharma Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 131,006 shares at $12.05 ($1.6M) on 2020-04-28, disclosed to the SEC on 2020-04-29.
Open-market purchase of $1.6M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.18 | 40,503 | $493K | 31.0% |
| 2 | $12.18 | 40,503 | $493K | 31.0% |
| 3 | $12.05 | 50,000 | $603K | 37.9% |
| Total | $12.13 avg | 131,006 | $1.6M | 100% |
| Filing → |
| MYOV | BUY | 2021-09-16 | $7.1M | — | Filing → |
| MYOV | BUY | 2021-09-08 | $3.4M | — | Filing → |
| MYOV | BUY | 2021-08-26 | $2.8M | — | Filing → |